Stablix Company
Stablix Therapeutics is a biotechnology company pioneering the field of Targeted Protein Stabilization (TPS).
Founded Date:
2021
Employee Number:
194
Headquarters:
New York, New York, United States
Funding Status:
Private
Industry:
Protein Degradation